Abstract
Introduction: Extrahepatic recurrence (EHR) is common after resection of colorectal liver metastases (CRLM). This study aimed to create a prediction model for early EHR (i.e., within two years) and to determine whether the risk of EHR impacted the effectiveness of perioperative treatments.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.